3765 related articles for article (PubMed ID: 6845797)
1. [Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].
Stenger D; Delbrück H; Krumrey K; Zaun H
Z Hautkr; 1983 Mar; 58(5):293-304. PubMed ID: 6845797
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous, cellular immunity in malignant melanoma].
Kehrer HC
Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
[No Abstract] [Full Text] [Related]
3. [Type IV immunity in alopecia areata in a comparison of 2 test methods].
Lutz G; Niedecken H; Bauer R; Kreysel HW
Z Hautkr; 1988 May; 63(5):391-2, 395-7. PubMed ID: 3261476
[TBL] [Abstract][Full Text] [Related]
4. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
5. [Cellular immunity in patients with melanoma].
Gorodinova VV; Kholenshed A; Babakova SV
Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
[TBL] [Abstract][Full Text] [Related]
6. [Evidence for tumor immunity in human malignant melanoma].
Nagel GA
Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017
[No Abstract] [Full Text] [Related]
7. [Testing of cellular immune reactivity in melanoma patients with diphenylcyclopropenone in comparison to dinitrochlorobenzol].
Mayerhausen W; Remy W
Hautarzt; 1987 Aug; 38(8):449-52. PubMed ID: 3654215
[TBL] [Abstract][Full Text] [Related]
8. Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.
Reuben JM; Hersh EM
Ann Allergy; 1984 Nov; 53(5):390-4. PubMed ID: 6594072
[TBL] [Abstract][Full Text] [Related]
9. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
10. [Climate therapy and change in cellular immunity].
Drosner M
Z Hautkr; 1988; 63 Suppl 4():104-7. PubMed ID: 3252623
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic response in patients with melanoma of the skin].
Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
Speiser DE; Pittet MJ; Rimoldi D; Guillaume P; Luescher IF; Liénard D; Lejeune F; Cerottini JC; Romero P
Semin Cancer Biol; 2003 Dec; 13(6):461-72. PubMed ID: 15001165
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
14. [Immunology of malignant melanoma].
Misgeld V
Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
[No Abstract] [Full Text] [Related]
15. [Current developments concerning malignant skin melanoma].
Dargent M
Maroc Med; 1972 Oct; 52(561):571-86. PubMed ID: 4667467
[No Abstract] [Full Text] [Related]
16. [Cellular immunity using skin tests in children with malignant diseases at the time of diagnosis and after therapy].
Göbel U; Körholz D; Janssen G; Schwamborn D; Jürgens H
Onkologie; 1987 Jun; 10(3 Suppl):4-7. PubMed ID: 3309761
[TBL] [Abstract][Full Text] [Related]
17. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
[No Abstract] [Full Text] [Related]
18. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
[No Abstract] [Full Text] [Related]
19. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
20. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T; Neidhard EM; Vignard V; Lefeuvre C; Adamski H; Labarrière N; Carsin A; Monnier D; Collet B; Clapisson G; Birebent B; Philip I; Toujas L; Chokri M; Quillien V
Clin Cancer Res; 2006 Dec; 12(24):7380-8. PubMed ID: 17189411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
